Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-29 @ 12:19 PM
Study NCT ID:
NCT07024550
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-18
First Post:
2025-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway
Sponsor:
BTL Industries Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-22
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-09
First Submit QC Date:
None
Study First Post Date:
2025-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-16
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL